Insider Trading: PDL BioPharma Inc (PDLI.O)

PDLI.O on Nasdaq

8.22USD
17 May 2013
Price Change (% chg)

$0.04 (+0.49%)
Prev Close
$8.18
Open
$8.23
Day's High
$8.25
Day's Low
$8.18
Volume
1,301,816
Avg. Vol
1,776,528
52-wk High
$8.43
52-wk Low
$6.16

Search Stocks
SANDMAN PAUL W Options Exercised: 0
Trade Date: Tuesday, 21 Jun 2011 Price: 5.89
Title: Director Shares Held: 35,372
Type Traded: Direct Net Change in Shares This Filing: 8,489

Institutional Holders

% Shares Owned: 94.86%
# of Holders: 277
Total Shares Held: 132,805,749
3 Mo. Net Change: -2,298,194
# New Positions: 31
# Closed Positions: 37
# Increased Positions: 125
# Reduced Positions: 106
# Net Buyers: 19

Officers & Directors

Name Age Since Current Position

John McLaughlin

61 2013 President, Chief Executive Officer, Director

Peter Garcia

52 2013 Chief Financial Officer, Acting Chief Accounting Officer, Vice President

Christopher Stone

47 2009 Vice President, General Counsel, Secretary

Danny Hart

36 2012 Deputy General Counsel, Assistant Secretary

Jody Lindell

61 2009 Independent Director

Paul Sandman

64 2008 Independent Director

Harold Selick

58 2009 Independent Director
Search Stocks